The post Bitcoin Climbs Back Above $73K as Tech Earnings and AI Boom Drive Market Momentum first appeared on TradingDots.

According to market trackers, more than 130 crypto ETF applications remain pending at the U.S. Securities and Exchange Commission (SEC). The agency’s slowdown during the shutdown dragged review timelines, especially for spot crypto funds. One analyst, James Seyffart of Bloomberg Intelligence, told industry media that once the regulatory machine resumes, “we could see many of these ETFs launch rather quickly.”

Amid that backdrop, filings for spot versions of XRP-based exchange-traded products appear to be approaching their final stages. Industry sources suggest the first U.S. spot XRP ETF could launch later this month. For example, the firm Canary Capital has filed a Form 8-A registration and is seeking to list under the ticker “XRPC” on the Nasdaq exchange.

The shutdown, which began on October 1, 2025, hampered many federal operations including the oversight work of the SEC. With funding restored, many market participants believe the crypto ETF process will regain its prior momentum.

Why it matters: Spot crypto ETFs represent a major bridge between crypto assets and traditional finance — by allowing institutional and retail investors to gain regulated exposure to digital assets via brokerage accounts. The restart of the approval process could unlock new capital flows and further legitimize the crypto-asset class.

What to watch:

• Whether the first spot XRP ETF lists this month under ticker XRPC
• How many other issuers follow that path
• How the SEC handles the surge of pending filings
• How the market responds to renewed ETF momentum, especially in terms of crypto asset performance and institutional engagement

Summary

• The government shutdown in the U.S. did impact regulatory agencies including the SEC, which delayed review timelines.
• Multiple crypto ETF filings are indeed reported to be pending, with over 130 crypto ETF/investment product filings cited in at least one source.
• Filings for spot XRP ETFs by major issuers (Canary Capital among them) are confirmed as being advanced.
• The claim that a spot XRP ETF will definitely launch this month is still speculative — some sources say “could” or “possible,” not guaranteed.
• The notion that the ETF approvals process is resuming with the government reopening is supported by coverage.

The post When Washington Shuts Down, Crypto Keeps Building: ETF Approvals Set to Resume first appeared on TradingDots.

The purchases were made via their regular buy-back programme, focusing on Treasury Inflation‑Protected Securities (TIPS) maturing between February 2040 and February 2055. According to reports, primary dealers submitted offers through the Federal Reserve Bank of New York’s FedTrade system. 

The backdrop is striking: the U.S. national debt approaches the $40 trillion mark, while macro-investors such as Ray Dalio are warning of a potential “economic heart attack” if deficits are not contained. Against this backdrop, crypto-advocates are highlighting digital assets as one potential avenue for investors seeking alternatives to traditional bonds.

So how does this debt buy-back tie into crypto? For one, reducing outstanding Treasury supply can affect bond yields and liquidity, which in turn influences investor sentiment across risk assets—including cryptocurrencies. The move may signal that Treasury managers want to tidy up older, less traded securities and shore up the market’s foundation ahead of whatever comes next.

For crypto markets, this could be interpreted two ways:

• On the one hand, if government debt becomes less appealing—or if fiscal concerns rise—some capital might shift into alternative assets such as crypto.
• On the other hand, rising yields or growing debt concerns could suppress risk appetite, which might weigh on high-volatility crypto instruments.

The key takeaway: this is a subtle but meaningful step in macro-fiscal policy that could ripple into crypto asset flows and market positioning. Investors and traders are wise to monitor debt-management operations, Treasury yield trends, and crypto market liquidity as interconnected variables.

Summary

• The debt buy-back by the U.S. Treasury was reported today for $142 million targeting TIPS maturing in 2040-2055.
• The article states that the buy-back is part of managing the debt crisis, which aligns with commentary by macro investors such as Ray Dalio warning about U.S. deficits.
• The link to crypto—that this fiscal move could affect crypto investment flows—is logical commentary, but not a direct causation guaranteed. That means the part about crypto advocates positioning assets as alternatives is plausible but more speculative.
• The data appears accurate per the source (cryptonews.com) and timings align with the reported “last updated” time.
• In summary: accurate on the core facts (the buy-back and its context); interpretative on the crypto implications.

The post U.S. Treasury Buys Back $142 Million in Debt — What It Means for Crypto first appeared on TradingDots.

One headline driver came from VivoPower (VVPR), which raised $19 million at $6.05/share to build a digital asset treasury focused on stacking XRP. The move makes it one of the first Nasdaq-listed firms to put serious capital directly into Ripple’s ecosystem.

At the same time, the CME Group — the world’s largest derivatives exchange — is preparing to roll out 24/7 crypto trading by early 2026, pending regulatory approval. While Bitcoin and Ethereum will lead the way, XRP and Solana options are scheduled to launch October 13, expanding institutional access beyond the top two coins.

CME says its crypto futures and options are already seeing record trading volumes, reflecting stronger regulatory support and growing demand from traditional finance. For Ripple, this shift could drive new liquidity, larger volumes, and greater mainstream exposure — factors that are already reflected in XRP’s chart.

Summary

• XRP Price: Back above $3.00 (+7% in October 2025).
• VivoPower (VVPR): Raised $19M to build XRP-focused digital treasury.
• CME Group: Expanding to 24/7 crypto trading (2026); XRP & Solana options launch Oct. 13, 2025.
• Market Impact: Boosts institutional exposure; strengthens XRP’s long-term case.

The post XRP Price Jumps Above $3 as CME Eyes 24/7 Crypto Trading first appeared on TradingDots.

Berkshire already owns 28% of Occidental and holds preferred shares and warrants in the company. Under the new agreement, $6.5 billion of the proceeds will be used to reduce Occidental’s principal debt. 

As part of a broader leadership transition, Buffett will stay on as chairman, while Greg Abel will take over as CEO — deepening his operational role as Berkshire’s next leader. 

The OxyChem deal is expected to close in the fourth quarter of 2025, expanding Berkshire’s industrial footprint alongside its existing holdings like Lubrizol.

Summary: What company is Berkshire Hathaway acquiring in its latest deal?
Berkshire Hathaway is acquiring Occidental Petroleum’s chemical division (OxyChem) in a $9.7 billion deal.

Why is this acquisition significant for Warren Buffett?
It could be Buffett’s last major deal before he steps down as CEO at the end of 2025, marking a defining moment in his legacy.

When is the OxyChem deal expected to close?
The acquisition is expected to close in the fourth quarter of 2025.

The post Berkshire Hathaway to Buy OxyChem in $9.7B Deal — Buffett’s Possible Final Big Move first appeared on TradingDots.

The move followed a brief dip to the $0.21 area late this week, a level that has repeatedly attracted buyers through August. Each test drew higher spot volumes on major exchanges, indicating that bids are concentrated around the same price band where selling pressure recently peaked. That reaction, coupled with a stabilizing crypto backdrop over the weekend, helped DOGE pivot back toward the mid-$0.22 zone and probe the $0.23 breakout area watched by technicians.

At the heart of the bullish argument is the emerging cup-and-handle formation on the daily chart. The “cup” developed across August as price rounded up from the $0.21 lows toward the mid-$0.23s, while the “handle” carved out during the late-month pullback. If buyers can confirm a clean daily close above the $0.23 neckline, chart projections imply a path toward $0.27 initially and, by extension, a retest of the psychological $0.30 region where sellers capped rallies earlier in the summer.

Context from recent sessions matters. On August 29, Dogecoin slid roughly 5% intraday as risk aversion picked up, briefly leaving the token on the brink of losing its August floor. Exchange data later showed that the $0.21–$0.215 pocket absorbed the heaviest spot selling, setting the stage for Saturday’s rebound. The persistence of that floor throughout August—and its ability to withstand bouts of broad-market stress—strengthens its role as immediate support.

Order-book structure now centers on two nearby levels: resistance around $0.23, where the neckline sits and resting offers have clustered, and support at $0.21, where bids continue to refresh. A decisive move through the former would shift attention to the $0.25 congestion band and the round-number magnet at $0.30. Failure, by contrast, would reopen a range back to $0.21, with little notable demand until the upper-$0.20s rebuild.

Derivatives signals have been constructive into the bounce. Open interest stabilized after the late-week washout, implying that forced deleveraging may have run its course. Pricing on perpetual futures narrowed toward spot, and funding rates flattened—conditions that often precede directional continuation if spot flows keep leaning bid. What the market needs to see next is follow-through volume on any $0.23 break; without that, false starts remain a risk.

On-chain activity offers a second tailwind. August wallet-tracking tallied sizeable accumulations by larger holders following each test of the $0.21 area, even as some whales sent tokens to exchanges during the dips. The push-pull reflects a market still redistributing supply after July’s swings, but the net effect near support favored absorption by longer-horizon buyers. Sustained net outflows from exchanges on green days would validate the constructive read.

Macro and sector drivers also factor into the setup. Bitcoin and ether’s choppy action into the U.S. macro calendar compressed altcoin ranges for much of the week, yet several high-beta tokens showed signs of basing before the majors stabilized—an unusual sequencing that some analysts read as early strength. If majors hold steady into the new month, beta rotation could give DOGE the liquidity it needs to complete the handle breakout.

For holders and traders, the implications are clear. A confirmed daily close above $0.23 would unlock a tactical run into $0.25 and then the bigger battleground at $0.30, where sellers previously defended aggressively. Momentum failure at the neckline keeps DOGE inside a $0.21–$0.23 range and preserves the risk of another liquidity sweep of the lows. Managing risk around those levels—using invalidation below $0.21 for breakout attempts or trimming into $0.25–$0.27 overhead—remains the pragmatic approach.

Looking ahead, traders are watching three dials: spot volume on any $0.23 break, exchange-reserve trends that signal whether supply is tightening, and derivatives metrics (open interest and funding) confirming that new longs are backing price rather than chasing it. With those aligned, the cup-and-handle blueprint points squarely at $0.30; without them, the pattern risks stalling into yet another rangebound week.

Where is the key breakout level?

Traders are focused on a daily close above $0.23. That clears the cup-and-handle neckline and opens room toward $0.25–$0.30.

What level supports the bullish case?

$0.21 has acted as a durable floor through August. Holding that zone keeps the setup intact; a clean loss would negate the pattern.

What confirms follow-through after a breakout?

Rising spot volume, stable or rising open interest, and neutral-to-positive funding. Together they indicate real demand rather than a fade.

The post Dogecoin rebounds from $0.21 floor as cup-and-handle eyes $0.30 first appeared on TradingDots.

This move comes amidst challenges from declining revenue—Coinbase’s trading volumes dropped by 39% in Q2, and overall earnings missed expectations, resulting in a 15% stock drop and the announcement of a $2 billion convertible bond issuance.

Social media users voiced frustration, likening the new fee to traditional bank charges. Ryan Sean Adams, co-founder of Bankless, highlighted concerns over future increases:

“What if this dropped to $10k. Feels like bank fees again.”

Hmmm…why

I don’t love the precedent here. What if this dropped to $10k. Feels like bank fees again @coinbase.

$1 USD = $1USDC right? pic.twitter.com/l9easdJM2t

— RYAN SΞAN ADAMS – rsa.eth 🦄 (@RyanSAdams) August 6, 2025

In response, Coinbase emphasized that the fee is part of an “experiment” aimed at evaluating how pricing affects USDC off-ramping, noting that similar or higher fees are already charged by competitors.

The fee structure targets a loophole exploited for arbitrage: users were converting USDT to USDC to off-ramp for free—USDT carries an exit fee, so swapping to USDC avoided that cost. Industry analysts, including influencer Cobie, acknowledged this strategic shift to safeguard USDC liquidity.

Despite this change, Coinbase continues to push its “everything exchange” strategy, reinforcing its reliance on stablecoins amid a shifting financial and competitive landscape.

What new fee is Coinbase introducing?
Coinbase will impose a 0.1% fee on USDC-to-USD conversions surpassing $5 million in net volume over any 30-day period, effective August 13, 2025.

Why is Coinbase implementing this fee now?
The change is a response to declining revenue and external competitive pressures, particularly to curtail arbitrage caused by USDT’s exit fee and to help manage liquidity and operational costs.

Is this fee applicable to all users?
No—it only affects high-volume traders and institutions exceeding the $5 million net conversion threshold. Retail users conducting smaller conversions remain unaffected.

The post Coinbase to Impose 0.1% Fee on USDC-to-USD Conversions Exceeding $5 Million first appeared on TradingDots.

Tariff Implications on Apple’s Bottom Line

Recent discussions around potential tariffs have raised concerns about their impact on Apple’s profitability. Analysts suggest that a 10% tariff on all Apple products imported into the U.S. could result in a 2% to 3% decline in earnings per share. To mitigate such effects, Apple may consider adjusting its pricing strategy, which could influence consumer demand and overall revenue.

Market Volatility and Investor Sentiment

The broader market has experienced increased volatility, with concerns over U.S. fiscal policy and rising Treasury yields contributing to investor unease. These macroeconomic factors have led to fluctuations in stock prices, including that of Apple, as investors reassess risk and return profiles in their portfolios.

Strategic Initiatives and Future Outlook

In response to these challenges, Apple is exploring strategic initiatives to bolster its market position. Efforts include diversifying its supply chain, investing in new technologies, and expanding its services segment to reduce reliance on hardware sales. These measures aim to enhance resilience against external shocks and sustain long-term growth.

Conclusion

While Apple faces headwinds from tariff concerns and market volatility, its proactive approach to strategic planning and diversification may help navigate these challenges. Investors will closely monitor the company’s performance and adaptability in the evolving economic landscape.

The post Apple Stock Faces Pressure Amid Tariff Concerns and Market Volatility first appeared on TradingDots.

President Donald Trump’s sweeping tax-cut bill faces resistance within Congress, raising concerns about its potential to increase the national debt by an estimated $3 to $5 trillion. This fiscal uncertainty has led investors to question the long-term stability of U.S. financial policies.

Compounding these concerns is the recent downgrade of the U.S. sovereign debt rating by Moody’s, which cited rising deficits and debt service costs as key factors. This move has further eroded confidence in U.S. assets, prompting a shift towards safer investments.

Internationally, the G7 finance ministers’ meeting in Banff, Alberta, has brought currency stability to the forefront.Discussions are expected to address issues such as excess manufacturing capacity, non-market economic practices, and financial crimes. U.S. Treasury Secretary Scott Bessent aims to encourage allies to confront China’s state-led, export-driven model, which contributes to global overcapacity.

The dollar index, which measures the U.S. currency against a basket of peers, edged down by 0.03% to 99.938, marking its lowest point since May 7. This decline has made dollar-priced assets more attractive to holders of other currencies, influencing market dynamics.

Federal Reserve officials have expressed caution regarding the economic impact of trade policies, signaling a “wait and see” approach to interest rate adjustments. Atlanta Fed President Raphael Bostic noted that previous efforts by companies to preempt tariffs are nearing their limit, and upcoming price changes will offer insight into consumer reactions.

As the U.S. navigates these fiscal challenges, the weakening dollar serves as a barometer of investor sentiment, reflecting broader concerns about economic stability and policy direction.

The post Dollar Slides as Fiscal Worries and G7 Discussions Intensify first appeared on TradingDots.

Adjusted earnings per share (EPS) for the quarter came in at $0.92, significantly ahead of Wall Street’s consensus estimate of $0.66. However, revenue totaled $13.7 billion, falling short of expectations for $14 billion. The stock edged up by less than 1% in pre-market trading following the announcement.

CEO Albert Bourla emphasized confidence in the company’s long-term prospects, citing strengthened research and development capabilities and ongoing productivity improvements. “With the underlying strength of our business, we believe we can be agile in navigating an uncertain and volatile external environment,” Bourla said in a statement.

Strategic Priorities: Plugging the Revenue Gap

Pfizer has been under growing scrutiny from analysts and shareholders as it grapples with declining COVID-19 revenuesand upcoming patent cliffs for several blockbuster drugs. The company is working aggressively to rebuild its product pipeline through a mix of internal development and acquisitions.

A central piece of this strategy is the $43 billion acquisition of Seagen, completed in 2024, which significantly boosts Pfizer’s oncology portfolio. One of Seagen’s key assets, Padcev, generated $1.6 billion in 2024 and is projected to contribute $3.1 billion annually at peak.

Pfizer reaffirmed its full-year 2025 guidance, expecting revenues between $61 and $64 billion and adjusted EPS of $2.80 to $3.00. Analysts view this as a positive sign of stability, although challenges remain.

Obesity Setback: Halted Trial Raises Concerns

One area of investor disappointment has been Pfizer’s effort to break into the high-growth obesity drug market, currently dominated by Eli Lilly (LLY) and Novo Nordisk (NVO). Hopes were high for Pfizer’s oral weight-loss therapy to serve as a differentiator, but the company was forced to halt its late-stage trial earlier this month due to a reported liver injury in a patient — a blow to its competitive ambitions in the sector.

Pfizer’s exit from the obesity race, at least in the near term, leaves Lilly and Novo with continued market leadership in the GLP-1 segment. For Pfizer, it underscores the importance of successfully leveraging its oncology and rare disease portfolios to drive near-term growth.

Investor Sentiment: Cautious Optimism

While the EPS beat and reaffirmed guidance provided some reassurance, the revenue miss and uncertainty around new drug development have led to measured investor reactions. Analysts broadly maintain a neutral to slightly bullishoutlook, contingent on clearer signals from the oncology pipeline and further commercialization of Seagen assets.

“Pfizer is in a transitional phase,” said Marla Vines, senior pharma analyst at Hightower Equity. “The market is giving it some room to maneuver, but execution on pipeline productivity is now critical.”

What’s Next: Focus on Oncology and Business Development

With lingering macro volatility and rising R&D costs, Pfizer will likely continue to pursue targeted acquisitions to shore up its late-stage pipeline. In the short term, much will hinge on the performance of newly acquired assets and updates from regulatory agencies regarding key approvals.

Upcoming investor calls and a mid-year R&D update will provide additional clarity on the company’s strategic roadmap. For now, Pfizer’s first-quarter results suggest early progress, but sustained momentum is far from guaranteed.

The post Pfizer Beats on EPS but Misses Revenue in Q1, Reaffirms 2025 Forecast first appeared on TradingDots.

What Triggered the Selloff?

Nvidia’s H20 chip was crafted as a lower-spec alternative to its H100 and H200 GPUs, tailored to comply with previous U.S. export controls. These chips offered reduced bandwidth and interconnect speeds — essentially, a “China-friendly” version of its cutting-edge products. But new rules require specific export licenses, effectively cutting off access for even the toned-down H20.

China, Nvidia’s fourth-largest market, delivered $17 billion in sales in fiscal year 2024. But last quarter, revenue from China was already down 50% due to earlier restrictions. The new export control compounds that problem, but investors may be overreacting to short-term noise.

Why the Dip Could Be a Golden Buying Opportunity

First off, not all Nvidia chips are off-limits. The company still sells other models like the L2 and L20, which remain in circulation — and let’s not ignore the existence of a robust gray market for Nvidia GPUs in China. That demand isn’t vanishing anytime soon.

Additionally, China lacks a homegrown alternative that can truly compete. While Huawei has stepped up with domestic AI chips, production hurdles persist. Huawei’s manufacturer, SMIC, is cut off from the EUV lithography machines needed for next-gen chip manufacturing. These tools, built only by ASML, are also restricted under current regulations. That puts a natural limit on how quickly China can close the technology gap.

Nvidia’s Strategic Reallocation Could Offset the Hit

With the H20 market closing, Nvidia has the option to redirect production lines toward more profitable products like Hopper and Blackwell chips. These flagship models command 2–4x the price of H20 units, meaning that, over time, Nvidia could offset lost revenue with higher-margin sales.

While retooling isn’t instantaneous, it’s feasible. Since H20 shares the same die as Hopper, transitioning production should be relatively smooth. Shifting to Blackwell is trickier due to its dual-die architecture and reliance on advanced packaging capacity at TSMC, which is already tight. Still, if Nvidia can secure that capacity, it could supercharge revenue in late 2025 and beyond.

The Long-Term Case for Nvidia Remains Strong

Despite regulatory turbulence, Nvidia remains the undisputed leader in AI infrastructure, and demand for its high-performance GPUs isn’t slowing. The company’s deep integration with hyperscalers, its leadership in developer ecosystems like CUDA, and the surging momentum in enterprise AI adoption mean Nvidia is more entrenched than ever.

In short: yes, the $5.5 billion charge stings, and yes, China’s a key market. But Nvidia’s global demand, innovation pipeline, and pricing power offer ample levers for recovery — and possibly outperformance — once the dust settles.

For investors with a medium- to long-term horizon, this could be a strategic moment to accumulate shares.

The post Nvidia Stock Falls on Export Control Warning—But It Might Be a Prime Buying Opportunity first appeared on TradingDots.

Sources familiar with the matter say the cuts are intended to streamline operations, flatten the management structure, and accelerate decision-making. Intel has yet to issue a public comment regarding the report.

This would be Intel’s largest round of layoffs since August 2024, when the company announced it would cut approximately 15% of its staff—about 15,000 jobs—as part of a broader $10 billion cost-saving plan. At that time, Intel cited rising operating expenses, shrinking profit margins in its core PC and data center businesses, and the high costs associated with catching up in the artificial intelligence chip market.

CEO Tan has already made moves to reorient the company’s direction. In his first weeks at the helm, he held a company-wide town hall where he warned of “tough decisions” ahead and outlined plans to rebuild Intel around an engineering-first culture. Tan has also begun flattening the company’s leadership hierarchy, with key chip teams now reporting directly to him, Reuters previously reported.

The anticipated job cuts are viewed as part of a broader effort to reset Intel’s long-term strategy. With mounting pressure from faster-moving competitors like Nvidia and AMD, Intel is attempting to shift its focus toward advanced chip development and more agile AI-driven product cycles.

As of the end of 2024, Intel employed roughly 108,900 people worldwide. The company is expected to report its first-quarter financial results on Thursday, and analysts will be watching closely for updates on the restructuring plan and any revisions to its AI and chip manufacturing roadmap.

The post Intel to Cut Over 20% of Workforce in Restructuring Drive, Bloomberg Reports first appeared on TradingDots.